Galera Therapeutics, Inc. (GRTX) › Shareholders' EquityGalera Therapeutics, Inc. (GRTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$76.11M2018: -$104.82M2019: $69.61M2020: $6.12M2021: -$58.00M2022: -$109.18M2023: -$131.19M2024: -$148.04M2025: $3.97M$3.97M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$3.97M+102.7%2024-$148.04M-12.8%2023-$131.19M-20.2%2022-$109.18M-88.2%2021-$58.00M-1048.1%2020$6.12M-91.2%2019$69.61M+166.4%2018-$104.82M-37.7%2017-$76.11M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share